New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic — an update from the EU Early Warning System

Lisbon December 2020

Series type: Rapid communication

Summary

In this update from the the EU Early Warning System aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency’s early warning and risk-assessment activities. The report covers the period until October 2020 and this year focuses on global markets, glocal threats and the COVID-19 pandemic.

Download as PDF

Table of contents

  • Purpose
  • Introduction
    • Background
    • Global markets, glocal threats and the COVID-19 pandemic
  • Situation in Europe
    • Overview of notifications
    • Overview of seizures, 2019
    • Opioids
    • Synthetic cannabinoids
    • Benzodiazepines
  • Global markets, glocal threats: the case for strengthened early warning, preparedness and response measures
  • References
  • Annexes
Publication cover
Pub. Author: 
EMCDDA
Pages: 
30
Price: 
Free
ISBN: 
978-92-9497-558-4
Pub. DOI: 
doi:10.2810/921262
Catalog Number: 
TD-03-20-796-EN-N

Related links: 

Main subject

NPS

Keywords

4F-MDMB-BICA
benzodiazepines
COVID-19
drug markets
early warning system
fentanils
isotonitazene
MDMB-4en-PINACA
NPS
opioids
piperazines
seizures of drugs
synthetic cannabinoids
synthetic cathinones
synthetic drugs

Target audience

general public
policymaker
researcher

Publications

Loading